ProCE Banner Activity

Biomarker Testing in Prostate Cancer: An Essential Component in Transforming Care

Slideset

Downloadable slideset from a medical oncologist and pathologist on testing for actionable mutations and using testing results to individualize PARP inhibitor–based therapy for patients with metastatic prostate cancer.

Released: March 27, 2024

Expiration: March 26, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with the American Society for Clinical Pathology

ProCE Banner

Supporters

Supported by an educational grant from Pfizer, Inc.

Pfizer, Inc.

Partners

American Society for Clinical Pathology

ProCE Banner